PharmD Live

MAY 30, 2024

Neurology (2015). British Journal of Clinical Pharmacology, 67(6), 689–700. Retrieved from British Journal of Clinical Pharmacology Jyrkka, J., British Journal of Clinical Pharmacology, 74(4), 627–633. Retrieved from British Journal of Clinical Pharmacology Family Caregiver Alliance.

Clinical Pharmacology 119

Clinical Pharmacology Hospitals Long-Term Care Facilities Dosage 119

pharmaphorum

MARCH 11, 2022

Vraylar, sold in some markets as Reagila, was first approved in 2015 for schizophrenia and bipolar disorder, with its label extended in 2017 to include maintenance treatment of schizophrenia and again in 2019 for bipolar depression.

Clinical Pharmacology 52

Clinical Pharmacology Labelling 52

RX Note

JANUARY 21, 2023

Introduction I still remember, during university years, there is a long list of recommended reading for each subject, which we might or might not give it a read. Regardless, this post is solely created as a collection of recommended reference.

Compounding 40

Compounding Community Pharmacies Clinical Pharmacology Dosage 40

European Pharmaceutical Review

MARCH 11, 2024

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. World Health Organization. The Global Health Observatory.

Immunization 98

Immunization Immunity Clinical Pharmacology Drug Development 98

The Thyroid Pharmacist

DECEMBER 28, 2022

Unfortunately, these types of clinical trials can be very expensive, and there isn’t a financial incentive for most companies to do this kind of research if they can’t collect a return on their investment. Then in 2015, I realized that we, the thyroid community, have the power to conduct our own research! Asia Pac J Clin Nutr.

Immunization 111

Immunization Immunity Clinical Pharmacology Doctor of Pharmacy 111

Putting Patients First Blog

SEPTEMBER 26, 2024

Clinical Pharmacology & Therapeutics , 97(3) , 263–273. Retrieved from https ://www.ahrq.gov/topics/individuals-special-health-care-needs.html#:~:text=The%20AHRQ%20Policy%20on%20the%20Inclusion%20of%20Priority,and %20justification%20is%20provided%20that%20inclusion%20is% 7 20inappropriateRamamoorthy, A., Pacanowski, M., 8 Scott, P.,

Communication 52

Communication Clinical Pharmacology Documentation Drug Development 52